文献速递水电解质与酸碱

枸橼酸钾与氯化钾补充剂对钾排泄及细胞内摄取的影响:随机对照试验

Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements: A Randomized Controlled Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-06-29

在这项纳入18名健康个体的安慰剂对照交叉干预试验中,单次口服枸橼酸钾(40 mmol)、氯化钾(40 mmol)或安慰剂后4小时内血浆钾升高幅度相似。枸橼酸钾后红细胞钾和跨管钾梯度(TTKG)高于氯化钾或赖诺普利预处理后的枸橼酸钾,且枸橼酸钾后TTKG变化与尿pH变化相关(R=0.60,P<0.001)。

要点

  • 单次口服枸橼酸钾、氯化钾或安慰剂后4小时内血浆钾升高幅度相似。
  • 枸橼酸钾后红细胞钾和TTKG高于氯化钾或赖诺普利预处理后的枸橼酸钾。
  • 枸橼酸钾后TTKG变化与尿pH变化相关(R=0.60,P<0.001)。

核心结论

  • 在血浆钾升高相似的情况下,单次口服枸橼酸钾后的红细胞钾摄取和钾排泄高于单用氯化钾或赖诺普利预处理后的枸橼酸钾。

研究设计与样本

  • 安慰剂对照交叉干预试验,纳入18名健康个体,随机顺序单次口服枸橼酸钾(40 mmol)、氯化钾(40 mmol)或安慰剂,分别在6周有或无赖诺普利预处理后进行。

主要发现

  • 4小时随访期间,所有干预后血浆钾升高幅度相似。
  • 枸橼酸钾后红细胞钾(细胞内钾的衡量指标)和跨管钾梯度(TTKG,反映钾分泌能力)高于氯化钾或赖诺普利预处理后的枸橼酸钾。
  • 基线醛固酮与枸橼酸钾后TTKG显著相关,但与氯化钾或赖诺普利预处理后的枸橼酸钾后TTKG不相关。
  • 枸橼酸钾后观察到的TTKG变化与该干预期间尿pH变化显著相关(R=0.60,P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A potassium replete diet is associated with lower cardiovascular risk but may increase the risk of hyperkalemia, particularly in people using renin-angiotensin-aldosterone system inhibitors. We investigated whether intracellular uptake and potassium excretion after an acute oral potassium load depend on the accompanying anion and/or aldosterone and whether this results in altered plasma potassium change. METHODS: In this placebo-controlled interventional cross-over trial including 18 healthy individuals, we studied the acute effects of one oral load of potassium citrate (40 mmol), potassium chloride (40 mmol), and placebo in random order after overnight fasting. Supplements were administered after a 6-week period with and without lisinopril pretreatment. Linear mixed effect models were used to compare blood and urine values before and after supplementation and between the interventions. Univariable linear regression was used to determine the association between baseline variables and change in blood and urine values after supplementation. RESULTS: During the 4-hour follow-up, the rise in plasma potassium was similar for all interventions. After potassium citrate, both red blood cell potassium-as measure of the intracellular potassium-and transtubular potassium gradient (TTKG)-reflecting potassium secretory capacity-were higher than after potassium chloride or potassium citrate with lisinopril pretreatment. Baseline aldosterone was significantly associated with TTKG after potassium citrate, but not after potassium chloride or potassium citrate with lisinopril pretreatment. The observed TTKG change after potassium citrate was significantly associated with urine pH change during this intervention ( R =0.60, P < 0.001). CONCLUSIONS: With similar plasma potassium increase, red blood cell potassium uptake and kaliuresis were higher after an acute load of potassium citrate as compared with potassium chloride alone or pretreatment with lisinopril. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Potassium supplementation in patients with chronic kidney disease and healthy subjects: effects on potassium and sodium balance, NL7618.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Wouda RD, Gritter M, Karsten M, et al. Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements: A Randomized Controlled Trial. Clin J Am Soc Nephrol. 2023. PMID: 37382933. doi:10.2215/CJN.0000000000000228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。